Epigenetic Rewiring of Enhancer–Promoter Interactions in Cancer: Mechanisms and Therapeutic Implications
Cancer is increasingly recognized as a disease of transcriptional dysregulation in which genetic alterations and epigenetic remodeling cooperate to reprogram gene regulatory networks that govern cellular identity, proliferation, differentiation, and therapeutic response. Enhancer–promoter interactions are an important...